Where does Cell and Molecular Tissue Engineering, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cell and Molecular Tissue Engineering, LLC ranks #34,696 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cell and Molecular Tissue Engineering, LLC hold?

Cell and Molecular Tissue Engineering, LLC holds 7 US utility patents granted between 2017 and 2024, spanning 8 technology areas.

What is Cell and Molecular Tissue Engineering, LLC's Innovation Score?

Cell and Molecular Tissue Engineering, LLC has an Innovation Score of 40.0 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cell and Molecular Tissue Engineering, LLC's patent grant rate increasing or decreasing?

Cell and Molecular Tissue Engineering, LLC's recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Cell and Molecular Tissue Engineering, LLC's patents?

Cell and Molecular Tissue Engineering, LLC's patents average 21.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cell and Molecular Tissue Engineering, LLC

Q: What technology areas does Cell and Molecular Tissue Engineering, LLC focus on?

Cell and Molecular Tissue Engineering, LLC's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 5 patents, ranking #1,311 of 3,490 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Q: How is the Cell and Molecular Tissue Engineering, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cell ranks #34,696 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#34,696
of 49,997 US assignees by volume: Top 37%
by Innovation Score (40.0/100): 21.3
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34696 · US Corporation #34,696 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,696/49,997
PHOTO-FINISH CathBuddy
CPC-NARROW A61M · 8 areas
INNOV-THIN 40.0/100
CLAIMS-DENSE 21.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: CathBuddy, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cell’s 40.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (18%) Velocity 10.0 pts (25%) Breadth 10.0 pts (25%) Claim depth 12.8 pts (32%)

Qualcomm Incorporated · highest

85
Cell and Molecular… · this assignee

40
3D Lighting… · lowest

7

What this shows Cell's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cell?

Each dot is one of Cell’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cell’s own 21.3 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cell vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cell's grants concentrate

Cell and Molecular Tissue Engineering, LLC is a focused PatentsView assignee: 8 CPC subclasses with 71.4% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). By volume, Cell sits between CathBuddy, Inc. and Cellink Bioprinting AB.

Cell's three-year grant acceleration

Cell and Molecular Tissue Engineering, LLC shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cathbuddy

7
Catheter Connecti…

7
Cazena

7
Cegnum

7
Cellavision AB

7
Cellaed Life Save…

7
Cellink AB

7
Cellink Bioprinti…

7
Cell and Molecula… ◀

7

What this shows Cell holds 7 patents at rank #34,801, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cell

By rank, the assignees closest to #34,801 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Cell's primary technology class.

Cell's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Cell and Molecular Tissue Engineering, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2018	1	14.3%
2019	1	14.3%
2020	1	14.3%
2022	1	14.3%
2023	1	14.3%
2024	1	14.3%

Which technologies does Cell and Molecular Tissue Engineering, LLC patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61B - DIAGNOSIS; SURGERY; Identification 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C07K - Peptides 3

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cell and Molecular Tissue Engineering, LLC's patent record in context - here's where to go next.

Cell and Molecular Tissue Engineering, LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 71.4% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #34,696 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cell and Molecular Tissue Engineering, LLC against CathBuddy, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.